💨 Abstract

Novavax's COVID-19 vaccine, the only traditional protein-based one in the U.S., is on track for full FDA approval after discussions to provide additional clinical data. The delay in approval, sparking concerns of political interference under Robert F. Kennedy Jr., has been reported, with FDA's acting commissioner directing a pause in the decision.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖